Data collection instruments | Time period | Data collected | Source |
---|---|---|---|
Screening questionnaire | Day of enrolment | Eligibility assessment | Self-report |
Participant assessment | Baseline 3, 6, and 12 month follow up | Demographic information, alcohol consumption, social problem solving styles, motivation/readiness to change, antiretroviral therapy (ART) history, adherence to ART, psychosocial factors associated with ART adherence (disclosure, HIV/AIDS stigma, social support, adherence self-efficacy), alcohol and ART beliefs, HIV-related factors (e.g. degree of ill-health between HIV diagnosis and ART initiation), clinical/structural factors (e.g. length of time to doctor), physical functioning (e.g. limitations due to physical health, bodily pain, vitality), general physical well-being, mental well-being, drug and tobacco use | Self-report |
Laboratory report form | Baseline, 3, 6, 12 month follow up | HIV-related outcomes: viral load (baseline and 12-month follow up assessments only) and CD4 counts | Laboratory report |
Alcohol biomarkers: Posphatidylethanol (PEth) | |||
Process evaluation interview schedule | 12-months follow-up | A randomly selected 10% subsample will respond to a qualitative interview regarding impressions of the degree to which the intervention helped or hindered behaviour change | Self-report |